Search research articles
Contact Us
Filters
Showing results (41-50 of 69) with videos related to
Page
of 7
Sort By:
European Journal of Epidemiology
|
October 23, 2012
Survival from breast cancer in relation to access to tertiary healthcare, body mass index, tumor characteristics and treatment: a Hellenic Cooperative Oncology Group (HeCOG) study
Paraskevi Panagopoulou, Helen Gogas, Nick Dessypris, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
December 21, 2004
Economic evaluation of gemcitabine in the treatment of pancreatic cancer in the UK
Mike Aristides, Michael Lees, Nick Botwood, et al.
BMC Health Services Research
|
August 22, 2009
Factors influencing prescribing behaviour of physicians in Greece and Cyprus: results from a questionnaire based survey
Mamas Theodorou, Vasiliki Tsiantou, Andreas Pavlakis, et al.
Cost Effectiveness and Resource Allocation : C/E
|
April 16, 2016
Cost-utility of ranibizumab versus aflibercept for treating Greek patients with visual impairment due to diabetic macular edema
Georgia Kourlaba, John Relakis, Ronan Mahon, et al.
Lung Cancer (Amsterdam, Netherlands)
|
December 31, 2003
Retrospective cost analysis of gemcitabine in combination with cisplatin in non-small cell lung cancer compared to other combination therapies in Europe
Joan Schiller, Dominic Tilden, Michael Aristides, et al.
BMC Health Services Research
|
December 16, 2014
Economic evaluation of ivabradine in the treatment of chronic heart failure in Greece
Georgia Kourlaba, John Parissis, Apostolos Karavidas, et al.
Clinical Drug Investigation
|
January 20, 2018
Cost-Effectiveness of Empagliflozin for the Treatment of Patients with Type 2 Diabetes Mellitus at Increased Cardiovascular Risk in Greece
George Gourzoulidis, Charalampos Tzanetakos, Ioannis Ioannidis, et al.
Journal of Global Oncology
|
September 28, 2018
Treating EGFR-Mutated Oncogene-Addicted Advanced Non-Small-Cell Lung Cancer in the Era of Economic Crisis in Greece: Challenges and Opportunities
Elena Fountzilas, Sofia Levva, Giannis Mountzios, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
September 10, 2014
The humanistic and economic burden of venous thromboembolism in cancer patients: a systematic review
Georgia Kourlaba, John Relakis, Charalambos Mylonas, et al.
Cancer Epidemiology
|
April 9, 2011
Early evaluation of an organised mammography screening program in Greece 2004-2009
Effie Simou, Dimitrios Tsimitselis, Maria Tsopanlioti, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 69) with videos related to
Sort By:
Page
of 7
European Journal of Epidemiology
|
October 23, 2012
Survival from breast cancer in relation to access to tertiary healthcare, body mass index, tumor characteristics and treatment: a Hellenic Cooperative Oncology Group (HeCOG) study
Paraskevi Panagopoulou, Helen Gogas, Nick Dessypris, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
December 21, 2004
Economic evaluation of gemcitabine in the treatment of pancreatic cancer in the UK
Mike Aristides, Michael Lees, Nick Botwood, et al.
BMC Health Services Research
|
August 22, 2009
Factors influencing prescribing behaviour of physicians in Greece and Cyprus: results from a questionnaire based survey
Mamas Theodorou, Vasiliki Tsiantou, Andreas Pavlakis, et al.
Cost Effectiveness and Resource Allocation : C/E
|
April 16, 2016
Cost-utility of ranibizumab versus aflibercept for treating Greek patients with visual impairment due to diabetic macular edema
Georgia Kourlaba, John Relakis, Ronan Mahon, et al.
Lung Cancer (Amsterdam, Netherlands)
|
December 31, 2003
Retrospective cost analysis of gemcitabine in combination with cisplatin in non-small cell lung cancer compared to other combination therapies in Europe
Joan Schiller, Dominic Tilden, Michael Aristides, et al.
BMC Health Services Research
|
December 16, 2014
Economic evaluation of ivabradine in the treatment of chronic heart failure in Greece
Georgia Kourlaba, John Parissis, Apostolos Karavidas, et al.
Clinical Drug Investigation
|
January 20, 2018
Cost-Effectiveness of Empagliflozin for the Treatment of Patients with Type 2 Diabetes Mellitus at Increased Cardiovascular Risk in Greece
George Gourzoulidis, Charalampos Tzanetakos, Ioannis Ioannidis, et al.
Journal of Global Oncology
|
September 28, 2018
Treating EGFR-Mutated Oncogene-Addicted Advanced Non-Small-Cell Lung Cancer in the Era of Economic Crisis in Greece: Challenges and Opportunities
Elena Fountzilas, Sofia Levva, Giannis Mountzios, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
September 10, 2014
The humanistic and economic burden of venous thromboembolism in cancer patients: a systematic review
Georgia Kourlaba, John Relakis, Charalambos Mylonas, et al.
Cancer Epidemiology
|
April 9, 2011
Early evaluation of an organised mammography screening program in Greece 2004-2009
Effie Simou, Dimitrios Tsimitselis, Maria Tsopanlioti, et al.
Page
of 7